# MEDX Xelerator

> MEDX Xelerator is a VC fund in Or Yehuda backing Medical and Health Care. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Or Yehuda, Israel
- Total investments: 6
- Last investment: Dec 2021
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/medx-xelerator-lp
- Website: https://www.medxelerator.com/

MEDX Xelerator is a unique medical device and digital health incubator. It was founded by MEDX Ventures Group, together with three partners: Boston Scientific, Intellectual Ventures’ Invention Science Fund and Sheba Medical Center. Each of MEDX Xelerator’s partners contributes outstanding core competencies, which complement one another and togethercreate a solid foundation for your success. Our incubator is seeking medical innovations for minimally invasive procedures, medical robotics, medical implants and digital health.Our vision is to leverage the power of MEDX Xelerator, and together with the extraordinary Israeli med tech innovation scene create a local cluster of entrepreneurial companies with breakthrough solutions to true unmet medical needs. Our mission is to nurture those promising technologies into successful medical ventures for the benefit of patients and health care professionals. We see you, the entrepreneur, as the key to success and we are here for you to make it happen.

## Contacts

5 contacts available for MEDX Xelerator. Shizune tracks 4 team members at MEDX Xelerator. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/medx-xelerator?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 5 | 83% |
| Health Care | 5 | 83% |
| Medical Device | 4 | 67% |
| Biotechnology | 2 | 33% |
| mHealth | 1 | 17% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 4 | 67% |
| Seed | 1 | 17% |
| Series A | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Shai Policker | CEO | 6 | https://shizune.co/investors/profile/shai-policker |
| Gal Atarot | Chief Technology Officer | 0 | https://shizune.co/investors/profile/gal-atarot |
| Harel Gadot | Founder | 1 | https://shizune.co/investors/profile/harel-gadot |
| Noam Taichler | Chief Financial Officer | 0 | https://shizune.co/investors/profile/noam-taichler |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| VeinWay | VeinWay is a medical device firm that develops a catheter for recanalizing chronic venous occlusions due to blockage or disease. |  | Pre-Seed | Dec 30, 2021 |  |
| Exero Medical | Exero Medical is a medical device manufacturing company. It develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI Surgery. Its system is designed to prevent complications by warning physicians of a potential leak, enabling early intervention.The company was founded in 2018 and is headquartered in OrYehuda, Israel. | $1.3M | Seed | Dec 15, 2021 |  |
| Append Medical | Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growingsegment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center. | $7.4M | Series A | Aug 04, 2021 |  |
| Dimoveo Medical | Dimoveo Medical develops internal body cavity disinfection technologies for implants, without needing to remove the implants from the body. | $800K | Pre-Seed | Oct 26, 2020 |  |
| Swift Duct | Swift Duct develops a navigational tool for the ERCP procedure, which minimizes the risk of infections in the pancreas. |  | Pre-Seed |  |  |
| Synchrony Medical | Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment. |  | Pre-Seed |  |  |

6 of 6 investments shown.

## Co-investors
- [Boston Scientific](https://shizune.co/investors/profile/boston-scientific) — VC Fund, 1 deal together
- [Consensus Business Group](https://shizune.co/investors/profile/consensus-business-group) — VC Fund, 1 deal together
- [Intellectual Ventures](https://shizune.co/investors/profile/intellectual-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does MEDX Xelerator invest in?

MEDX Xelerator invests primarily in Medical, Health Care and Medical Device startups, most often at Pre-Seed and Seed stage. Most of the 6 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact MEDX Xelerator?

Public channels for MEDX Xelerator include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at MEDX Xelerator?

The team at MEDX Xelerator includes Shai Policker (CEO), Gal Atarot (Chief Technology Officer) and Harel Gadot (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co